{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:39:11Z","timestamp":1759333151506},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s10822-013-9674-2","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T11:31:54Z","timestamp":1377257514000},"page":"739-754","source":"Crossref","is-referenced-by-count":11,"title":["Human farnesyl pyrophosphate synthase inhibition by nitrogen bisphosphonates: a 3D-QSAR study"],"prefix":"10.1007","volume":"27","author":[{"given":"David","family":"Fern\u00e1ndez","sequence":"first","affiliation":[]},{"given":"Joaqu\u00edn","family":"Ortega-Castro","sequence":"additional","affiliation":[]},{"given":"Juan","family":"Frau","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,8,24]]},"reference":[{"key":"9674_CR1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1210\/jc.76.6.1397","volume":"76","author":"H Fleisch","year":"1993","unstructured":"Fleisch H (1993) Editorial: prospective use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab 76:1397\u20131398","journal-title":"J Clin Endocrinol Metab"},{"key":"9674_CR2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pharmtox.38.1.375","volume":"38","author":"GA Rodan","year":"1998","unstructured":"Rodan GA (1998) Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol 38:375\u2013388","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9674_CR3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1006\/bbrc.1999.1404","volume":"263","author":"MB Martin","year":"1999","unstructured":"Martin MB, Arnold W, Heath HT III, Urbina JA, Oldfield E (1999) Nitrogen-containing bisphosphonates as carbocation transition state analogs for isoprenoid biosynthesis. Biochem Biophys Res Commun 263:754\u2013758","journal-title":"Biochem Biophys Res Commun"},{"key":"9674_CR4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/annonc\/mdi162","volume":"16","author":"RE Coleman","year":"2005","unstructured":"Coleman RE (2005) Bisphosphonates in breast cancer. Ann Oncol 16:687\u2013695","journal-title":"Ann Oncol"},{"key":"9674_CR5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/BF03401961","volume":"7","author":"H Sicard","year":"2001","unstructured":"Sicard H, Al Saati T, Delsol G, Fourni\u00e9 JJ (2001) Synthetic phosphoantigens enhance human V\u03b39\u00a0V\u03b42T lymphocytes killing of non-Hodgkin\u2019s B lymphoma. Mol Med 7:711\u2013722","journal-title":"Mol Med"},{"key":"9674_CR6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood-2002-12-3665","volume":"102","author":"M Wilhelm","year":"2003","unstructured":"Wilhelm M, Kunzmann V, Eckstein S, Reimer P, Weissinger F, Ruediger T, Tony HP (2003) \u03b3\u03b4T cells for immune therapy of patients with lymphoid malignancies. Blood 102:200\u2013206","journal-title":"Blood"},{"key":"9674_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2007.07.007","volume":"257","author":"V Stresing","year":"2007","unstructured":"Stresing V, Daubin\u00e9 F, Benzaid I, M\u00f6nkk\u00f6nen H, Cl\u00e9zardin P (2007) Bisphosphonates in cancer therapy. Cancer Lett 257:16\u201335","journal-title":"Cancer Lett"},{"key":"9674_CR8","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1021\/jm0102809","volume":"45","author":"MB Martin","year":"2002","unstructured":"Martin MB, Sanders JM, Kendrick H, Luca-Fradley K, Lewis JC, Grimley JS, Van Brussel EM, Olsen JR, Meints GA, Burzynska A, Kafarski P, Croft SL, Oldfield E (2002) Activity of bisphosphonates against trypanosoma brucei rhodesiense. J Med Chem 45:2904\u20132914","journal-title":"J Med Chem"},{"key":"9674_CR9","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1016\/j.jorganchem.2009.07.025","volume":"694","author":"E D\u0105browska","year":"2009","unstructured":"D\u0105browska E, Burzy\u0144ska A, Mucha A, Matczak-Jon E, Sawka-Dobrowolska W, Berlicki L, Kafarski P (2009) Insight into the mechanism of three component condensation leading to aminomethylenebisphosphonates. J Org Chem 694:3806\u20133813","journal-title":"J Org Chem"},{"key":"9674_CR10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/jcb.23049","volume":"112","author":"B Baojie Li","year":"2011","unstructured":"Baojie Li B, Chau JFL, Wang X, Leong WF (2011) Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy. J Cell Biochem 112:1229\u20131242","journal-title":"J Cell Biochem"},{"key":"9674_CR11","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/jm7015733","volume":"51","author":"JE Dunford","year":"2008","unstructured":"Dunford JE, Kwaasi AA, Rogers MJ, Barnett BL, Ebetino FH, Russell RGG, Oppermann U, Kavanagh KL (2008) Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. J Med Chem 51:2187\u20132195","journal-title":"J Med Chem"},{"key":"9674_CR12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","volume":"65","author":"FL Zhang","year":"1996","unstructured":"Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241\u2013269","journal-title":"Annu Rev Biochem"},{"key":"9674_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1388-1981(00)00009-3","volume":"1484","author":"M Sinensky","year":"2000","unstructured":"Sinensky M (2000) Recent advances in the study of prenylated proteins. Biochim Biophys Acta 1484:93\u2013106","journal-title":"Biochim Biophys Acta"},{"key":"9674_CR14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2141.1997.2713086.x","volume":"98","author":"CM Shipman","year":"1997","unstructured":"Shipman CM, Rogers MJ, Apperley JF, Russell RG, Croucher PI (1997) Bisphosphonates induce apoptosis in human myeloma cell lines; a novel anti-tumour activity. Br J Haematol 98:665\u2013672","journal-title":"Br J Haematol"},{"key":"9674_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1402.089","volume":"1117","author":"RG Russell","year":"2007","unstructured":"Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Davanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH (2007) Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117:209\u2013257","journal-title":"Ann N Y Acad Sci"},{"key":"9674_CR16","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1021\/ja808285e","volume":"131","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Cao R, Yin F, Hudock MP, Guo R-T, Krysiak K, Mukherjee S, Gao Y-G, Robinson J, Song Y, No JH, Bergan K, Leon A, Cass L, Goddard A, Chang T-K, Lin F-Y, Van Beek E, Papapoulos S, Wang AH-J, Kubo T, Ochi M, Mukkamala D, Oldfield E (2009) Lipophilic bisphosphonates as dual farnesyl\/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation. J Am Chem Soc 131:5153\u20135162","journal-title":"J Am Chem Soc"},{"key":"9674_CR17","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1359\/jbmr.1997.12.9.1358","volume":"12","author":"JC Frith","year":"1997","unstructured":"Frith JC, M\u00f6nkk\u00f6nen J, Blackburn M, Russell RGG, Rogers MJ (1997) Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5`-(\u03b2, \u03b3-dichloromethylene) triphosphate, by mammalian Cells in vitro. J Bone Miner Res 12:1358\u20131367","journal-title":"J Bone Miner Res"},{"key":"9674_CR18","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1021\/bi00202a004","volume":"33","author":"LC Tarshis","year":"1994","unstructured":"Tarshis LC, Yan M, Poulter CD, Sacchettini JC (1994) Crystal structure of recombinant farnesyl diphosphate synthase at 2.6-\u212b resolution. Biochemistry 33:10871\u201310877","journal-title":"Biochemistry"},{"key":"9674_CR19","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1073\/pnas.93.26.15018","volume":"93","author":"LC Tarshis","year":"1996","unstructured":"Tarshis LC, Proteau P, Poulter CD, Sacchettini JC (1996) Regulation of product chain length by isoprenyl diphosphate synthases. Proc Natl Acad Sci 93:15018\u201315023","journal-title":"Proc Natl Acad Sci"},{"key":"9674_CR20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/prot.20754","volume":"62","author":"SB Gabelli","year":"2005","unstructured":"Gabelli SB, McLellan JS, Montalvetti A, Oldfield E, Docampo R, Amzel LM (2005) Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design. Proteins 62:80\u201388","journal-title":"Proteins"},{"key":"9674_CR21","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.0601643103","volume":"103","author":"KL Kavanagh","year":"2006","unstructured":"Kavanagh KL, Guo K, Dunford JE, Wu X, Knapp S, Ebetino FH, Rogers MJ, Russell RG, Oppermann U (2006) The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc Natl Acad Sci 103:7829\u20137834","journal-title":"Proc Natl Acad Sci"},{"key":"9674_CR22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/cmdc.200500059","volume":"1","author":"JM Rondeau","year":"2006","unstructured":"Rondeau JM, Bitsch F, Bourgier E, Geiser M, Hemming R, Kroemer M, Lehmann S, Ramage P, Rieffel S, Strauss A, Green JR, Jahnke W (2006) Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs. ChemMedChem 1:267\u2013273","journal-title":"ChemMedChem"},{"key":"9674_CR23","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1021\/jm201657x","volume":"55","author":"YS Lin","year":"2012","unstructured":"Lin YS, Park J, De Schutter JW, Huang XF, Berghuis AM, Sebag M, Tsantrizos YS (2012) Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells. J Med Chem 55:3201\u20133215","journal-title":"J Med Chem"},{"key":"9674_CR24","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1021\/jm010279+","volume":"45","author":"CM Szabo","year":"2002","unstructured":"Szabo CM, Martin MB, Oldfield E (2002) An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs. J Med Chem 45:2894\u20132903","journal-title":"J Med Chem"},{"key":"9674_CR25","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1021\/jm0302344","volume":"46","author":"JM Sanders","year":"2003","unstructured":"Sanders JM, G\u00f3mez AO, Mao J, Meints GA, Van Brussel EM, Burzynska A, Kafarski P, Gonz\u00e1lez-Pacanoska D, Oldfiel E (2003) 3D-QSAR investigation of the inhibition of leishmania major farnesyl pyrophosphate synthase by bisphosphonates. J Med Chem 46:5171\u20135183","journal-title":"J Med Chem"},{"key":"9674_CR26","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","volume":"366","author":"M Whitaker","year":"2012","unstructured":"Whitaker M, Guo J, Kehoe T, Benson G (2012) Perspective: bisphosphonates for osteoporosis - where do we go from here? N Engl J Med 366:2048\u20132051","journal-title":"N Engl J Med"},{"key":"9674_CR27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.amjmed.2008.01.047","volume":"121","author":"LM Hess","year":"2008","unstructured":"Hess LM, Jeter JM, Benham-Hutchins M, Alberts DS (2008) Factors associated with osteonecrosis of the jaw among bisphophonates users. Am J Med 121:475\u2013483","journal-title":"Am J Med"},{"key":"9674_CR28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00774-007-0837-x","volume":"26","author":"F Bauss","year":"2008","unstructured":"Bauss F, Pfister T, Papapoulos S (2008) Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat. J Bone Miner Metab 26:406\u2013408","journal-title":"J Bone Miner Metab"},{"key":"9674_CR29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev.med.60.063007.134350","volume":"60","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Mehrotra B (2009) Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management. Annu Rev Med 60:85\u201396","journal-title":"Annu Rev Med"},{"key":"9674_CR30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jama.2011.190","volume":"305","author":"LP Park-Wyllie","year":"2011","unstructured":"Park-Wyllie LP, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler JP, Laupacis A (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305:783\u2013789","journal-title":"JAMA"},{"key":"9674_CR31","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","volume":"110","author":"RD Cramer III","year":"1988","unstructured":"Cramer RD III, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959\u20135967","journal-title":"J Am Chem Soc"},{"key":"9674_CR32","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1021\/jm00050a010","volume":"37","author":"G Klebe","year":"1994","unstructured":"Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130\u20134146","journal-title":"J Med Chem"},{"key":"9674_CR33","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1021\/jm030054u","volume":"46","author":"E Kotsikorou","year":"2003","unstructured":"Kotsikorou E, Oldfield E (2003) A quantitative structure-activity relationship and pharmacophore modelling investigation of aryl-X and heterocyclic bisphosphonate as bone resorption agents. J Med Chem 46:2932\u20132944","journal-title":"J Med Chem"},{"key":"9674_CR34","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jcc.540100804","volume":"10","author":"M Clark","year":"1989","unstructured":"Clark M, Cramer RD III, Van Opdenbosch N (1989) Validation of the general purpose Tripos 5.2 force field. J Comp Chem 10:982\u20131012","journal-title":"J Comp Chem"},{"key":"9674_CR35","unstructured":"SYBYL 8.0 Tripos Inc., 1699 South Hanley Rd. St. Louis, Missouri, 63144-2917"},{"key":"9674_CR36","unstructured":"NBO Version 3.1, Glendening ED, Reed AE, Carpenter JE, Weinhold F"},{"key":"9674_CR37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1063\/1.449486","volume":"83","author":"AE Reed","year":"1985","unstructured":"Reed AE, Weinstock RB, Weinhold F (1985) Natural-population analysis. J Chem Phys 83:735\u2013746","journal-title":"J Chem Phys"},{"key":"9674_CR38","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1021\/cr00088a005","volume":"88","author":"AE Reed","year":"1988","unstructured":"Reed AE, Curtiss LA, Weinhold F (1988) Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint. Chem Rev 88:899\u2013926","journal-title":"Chem Rev"},{"key":"9674_CR39","unstructured":"Gaussian 09, Revision B.1, Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery Jr. JA, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant J. C, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas \u00d6, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ. Gaussian, Inc., Wallingford CT, 2009"},{"key":"9674_CR40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0166-1280(96)04936-6","volume":"398","author":"FA Weinhold","year":"1997","unstructured":"Weinhold FA (1997) Nature of H-bonding in clusters, liquids, and enzymes: an ab initio, natural bond orbital perspective. J Mol Struct (Theochem) 398:181\u2013197","journal-title":"J Mol Struct (Theochem)"},{"key":"9674_CR41","doi-asserted-by":"crossref","unstructured":"Kubinyi H (1998) Comparative molecular field analysis (CoMFA). In: Schleyer PvR, Allinger NL, Clark T, Gasteiger J, Kollman PA, Schaefer III HF, Schreiner PR (eds) The encyclopedia of computational chemistry, vol 1. Wiley, Chichester, p 448\u2013460","DOI":"10.1002\/0470845015.cca030"},{"key":"9674_CR42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/ci00063a006","volume":"29","author":"VN Viswanadhan","year":"1989","unstructured":"Viswanadhan VN, Ghose AK, Revankar GR, Robins RK (1989) Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J Chem Inf Comput Sci 29:163\u2013172","journal-title":"J Chem Inf Comput Sci"},{"key":"9674_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-2670(86)80028-9","volume":"185","author":"P Geladi","year":"1986","unstructured":"Geladi P, Kowalski B (1986) Partial least-squares regression: a tutorial. Anal Chim Acta 185:1\u201317","journal-title":"Anal Chim Acta"},{"key":"9674_CR44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10629360008033231","volume":"11","author":"K Hasegawa","year":"2000","unstructured":"Hasegawa K, Funatsu K (2000) Partial least squares modelling and genetic algorithm optimization in quantitative structure-activity relationships. SAR QSAR Environ Res 11:189\u2013209","journal-title":"SAR QSAR Environ Res"},{"key":"9674_CR45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/00401706.1978.10489693","volume":"20","author":"S Wold","year":"1978","unstructured":"Wold S (1978) Cross-validatory estimation of the number of components in factor and principal components models. Technometrics 20:397\u2013406","journal-title":"Technometrics"},{"key":"9674_CR46","unstructured":"MarvinSketch 5.7, Calculator Plugin and Chemical Terms Demo Copyright \u00a9 1999\u20132012 ChemAxon Ltd"},{"key":"9674_CR47","unstructured":"SPARC Performs Automated Reasoning in Chemistry. Sparc v4.6"},{"key":"9674_CR48","unstructured":"Haynes WM (2012) CRC Handbook of Chemistry and Physics 93th edn. Taylor & Francis Group"},{"key":"9674_CR49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/jo01066a039","volume":"26","author":"H Walba","year":"1961","unstructured":"Walba H, Isensee RW (1961) Acidity constants of some arylimidazoles and their cations. J Org Chem 26:289\u20132791","journal-title":"J Org Chem"},{"key":"9674_CR50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1093-3263(01)00123-1","volume":"20","author":"A Golbraikh","year":"2002","unstructured":"Golbraikh A, Tropsha A (2002) Beware of q2! J Mol Graph Model 20:267\u2013276","journal-title":"J Mol Graph Model"},{"key":"9674_CR51","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","volume":"36","author":"J Gasteiger","year":"1980","unstructured":"Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electronegativity: a rapid access to atomic charges. Tetrahedron 36:3219\u20133228","journal-title":"Tetrahedron"},{"key":"9674_CR52","first-page":"601","volume":"53","author":"M Marsili","year":"1980","unstructured":"Marsili M, Gasteiger J (1980) \u03c0 Charge distribution from molecular topology and \u03c0 orbital electronegativity. Croat Chem Acta 53:601\u2013614","journal-title":"Croat Chem Acta"},{"key":"9674_CR53","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1063\/1.477924","volume":"110","author":"JA Montgomery Jr","year":"1999","unstructured":"Montgomery JA Jr, Frisch MJ, Ochterski JW, Petersson GA (1999) A complete basis set model chemistry. VI. Use of density functional geometries and frequencies. J Chem Phys 110:2822\u20132827","journal-title":"J Chem Phys"},{"key":"9674_CR54","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1063\/1.481224","volume":"112","author":"JA Montgomery Jr","year":"2000","unstructured":"Montgomery JA Jr, Frisch MJ, Ochterski JW, Petersson GA (2000) A complete basis set model chemistry. VII. Use of the minimum population localization method. J Chem Phys 112:6532\u20136542","journal-title":"J Chem Phys"},{"key":"9674_CR55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jcc.540050204","volume":"5","author":"UC Singh","year":"1984","unstructured":"Singh UC, Kollman PA (1984) An approach to computing electrostatic charges for molecules. J Comp Chem 5:129\u2013145","journal-title":"J Comp Chem"},{"key":"9674_CR56","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jcc.540110404","volume":"11","author":"BH Besler","year":"1990","unstructured":"Besler BH, Merz KM Jr, Kollman PA (1990) Atomic charges derived from semiempirical methods. J Comp Chem 11:431\u2013439","journal-title":"J Comp Chem"},{"key":"9674_CR57","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jcc.540110311","volume":"11","author":"CM Breneman","year":"1990","unstructured":"Breneman CM, Wiberg KB (1990) Determining atom-centered monopoles from molecular electrostatic potentials. The need for high sampling density in formamide conformational analysis. J Comp Chem 11:361\u2013373","journal-title":"J Comp Chem"},{"key":"9674_CR58","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/092986711794088335","volume":"18","author":"K Ohno","year":"2011","unstructured":"Ohno K, Mori K, Orita M, Takeuchi M (2011) Computational insights into binding of bisphosphates to farnesyl pyrophosphate synthase. Curr Med Chem 18:220\u2013233","journal-title":"Curr Med Chem"},{"key":"9674_CR59","doi-asserted-by":"crossref","first-page":"12377","DOI":"10.1074\/jbc.M607286200","volume":"282","author":"CE Sanz-Rodr\u00edguez","year":"2007","unstructured":"Sanz-Rodr\u00edguez CE, Concepci\u00f3n JL, Pekerar S, Oldfield E, Urbina JA (2007) Bisphosphonates as inhibitors of trypanosoma cruzi hexokinase: kinetic and metabolic studies. J Biol Chem 282:12377\u201312387","journal-title":"J Biol Chem"},{"key":"9674_CR60","doi-asserted-by":"crossref","first-page":"o1025","DOI":"10.1107\/S1600536811011408","volume":"67","author":"W Feng-Lei","year":"2011","unstructured":"Feng-Lei W, Rong-Xin Y, Ji-Min X (2011) 4-[2-(Hydrogen phosphonate)-2-hydroxy-2-phosphonoethyl]pyridinium. Acta Cryst. E 67:o1025","journal-title":"Acta Cryst. E"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-013-9674-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-013-9674-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-013-9674-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T02:09:02Z","timestamp":1715911742000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-013-9674-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["9674"],"URL":"https:\/\/doi.org\/10.1007\/s10822-013-9674-2","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}